Predictive modeling of aspirin‐triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome
Abstract Objectives Sjögren's syndrome (SS) is an autoimmune disease that causes chronic inflammation of the salivary glands leading to secretory dysfunction. Previous studies demonstrated that aspirin‐triggered resolvin D1 (AT‐RvD1) reduces inflammation and restores tissue integrity in salivar...
Main Authors: | Venkata Kashyap Yellepeddi, Olga J. Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-04-01
|
Series: | Clinical and Experimental Dental Research |
Subjects: | |
Online Access: | https://doi.org/10.1002/cre2.260 |
Similar Items
-
Physiologically Based Pharmacokinetics Model in Pregnancy: A Regulatory Perspective on Model Evaluation
by: Paola Coppola, et al.
Published: (2021-06-01) -
Prediction of a Therapeutic Dose for Buagafuran, a Potent Anxiolytic Agent by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Starting from Pharmacokinetics in Rats and Human
by: Fen Yang, et al.
Published: (2017-10-01) -
Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles
by: Carlander U, et al.
Published: (2016-02-01) -
An integrated exposure and pharmacokinetic modeling framework for assessing population-scale risks of phthalates and their substitutes
by: Yaoxing Wu, et al.
Published: (2021-11-01) -
Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates
by: Lukas Kovar, et al.
Published: (2020-06-01)